Dolce Pharmaceuticals Private Limited, a active private limited company, was established on 23 November 1994 in Boisar, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24200MH1994PTC083218. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹3.50 Cr.
It upholds a compliant status. Its leadership includes Rakhi Gopakumar Nair (Director), Milind Vinayakrao Gadkari (Director), Gopakumar Prabhakar Nair (Director). Past directors included Vijay Vasant Dhavale, Nagesh Shripad Jere, Vidyadhar Marathe. It holds ₹13.70 Cr open charges and no settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at 101, Beena Apartment, Opp. Ram Mandir, Navapur Road, Boisar, Taluka Palghar, Boisar, Maharashtra, 401501.
U24200MH1994PTC083218
083218
23 November 1994
₹3.50 Cr
₹3.50 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Dolce Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakhi Gopakumar Nair | Director | 23 Mar 2010 | Current |
| Milind Vinayakrao Gadkari | Director | 05 Mar 2016 | Current |
| Gopakumar Prabhakar Nair | Director | 23 Mar 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Feb 2015 | Past |
| Pramod Abcsdd | Managing Director | 06 Apr 2010 | Past |
| Pramod Abcsdd | Director | 11 Apr 2011 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dolce Pharmaceuticals Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 145285% increase. The company also saw a substantial fall in profitability, with a 295.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 73.39%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Dolce Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹136,991,189.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Feb 2018 | Others | ₹13.70 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Dolce Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Dolce Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dolce Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Dolce Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was recorded as a recent event.
Progress on A charge with Others of Rs. 13.70 Cr registered on 20 Feb 2018 with Charge ID 100157573 was modified on 16 Sep 2020. was documented.
Progress on Dolce Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Mumbai. was documented.
Progress on A charge with Others amounted to Rs. 13.70 Cr with Charge ID 100157573 was registered on 20 Feb 2018. was documented.
The activity Milind Vinayakrao Gadkari was appointed as a Director was appointed as a Director on 05 Mar 2016 & has been associated with this company since 9 years 8 months . was completed.
Progress on Rakhi Gopakumar Nair was appointed as a Director was appointed as a Director on 23 Mar 2010 & has been associated with this company since 15 years 8 months . was documented.
The CIN of Dolce Pharmaceuticals Private Limited is U24200MH1994PTC083218.
Dolce Pharmaceuticals Private Limited is headquartered at 101, Beena Apartment, Opp. Ram Mandir, Navapur Road, Boisar, Taluka Palghar, Boisar, Maharashtra, 401501.
Dolce Pharmaceuticals Private Limited was incorporated on 23 November 1994.
The current directors of Dolce Pharmaceuticals Private Limited are
The primary industry of Dolce Pharmaceuticals Private Limited is Manufacturing.
Dolce Pharmaceuticals Private Limited is unlisted.
The authorized capital of Dolce Pharmaceuticals Private Limited is ₹3.50 Cr, and the paid-up capital is ₹3.50 Cr.
The compliance status of Dolce Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX